Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has submitted a routine compliance certificate to NSE and BSE under SEBI's Depositories Regulations, 2018. The certificate, issued by its Registrar KFin Technologies, confirms that details of all shares dematerialized or rematerialized during the quarter ended June 30, 2025, have been reported to the stock exchanges. The dematerialized securities continue to be listed on the same stock exchanges where the company's shares are originally listed. This is a standard quarterly regulatory filing with no operational or financial information disclosed.
This is a routine procedural filing required by SEBI every quarter and has no direct impact on the company's business, financials, or share price. Retail investors can safely treat it as administrative housekeeping.